Kidney disease in Aboriginal Australians: A perspective from the Northern Territory

Clinical Kidney Journal

Volumn 7, Issue 6, 2014, Pages

  Hoy, Wendy E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINURIA; ARTICLE; AUSTRALIA; AUSTRALIAN ABORIGINE; AWARENESS; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL RESEARCH; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL (TOPIC); CULTURAL ANTHROPOLOGY; DISEASE ASSOCIATION; FOCAL GLOMERULOSCLEROSIS; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH SERVICE; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; INCIDENCE; INDIGENOUS HEALTH CARE; INDIGENOUS PEOPLE; KIDNEY DISEASE; KIDNEY FAILURE; MANAGED CARE; METABOLIC REGULATION; MORTALITY; PERITONEAL DIALYSIS; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS;

EID: 84928388106     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfu109     Document Type: Article

References (60)

1. Australian Bureau of Statistics. Reflecting a Nation: Stories from the 2011 Census, July 2011. Cat. No. 2071.0. http://www. abs.gov.au/AUSSTATS/abs.nsf/DetailsPage/2071.0July% 202011 (15 August 2013, date last accessed)
2. Australian Bureau of Statistics. The Health and Welfare of Australia's Aboriginal and Torres Strait Islander Peoples, Oct 2010 (Cat. No. 4704.0). http://www.abs.gov.au/AUSSTATS/abs.nsf/lookup/4704.0Chapter200Oct+2010
3. Spencer JS, Silva D, Hoy WE. An epidemic of renal failure among Australian Aborigines. Med J Aust 1998; 168: 537-541.
4. McDonald S, Jose M, Hurst K. End-stage kidney disease among indigenous peoples of Australia and New Zealand. Chapter 12:1-19. ANZDATA Registry 2012 Report. Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia. http://www.anzdata.org.au/anzdata/Anzdata Report/35thReport/2012c12-indigenousv2.4.pdf (29 October 2013, date last accessed)
5. Barker DJ. The developmental origins of adult disease. Eur J Epidemiol 2003; 18: 733-736
6. Hoy WE, Kile E, Rees M et al. Low birth weight and renal disease in Australian Aborigines. Lancet 1998; 352: 1826-1827
7. HoyWE, Nichol JL. Birth weight and natural deaths in a remote Australian Aboriginal community. Med J Aust 2010; 192: 14-19
8. You J, Hoy WE, Zhao Y et al. End-stage renal disease in the Northern Territory: current and future treatment costs. Med J Aust 2002; 176: 461-465
9. Baker PRA, Hoy WE, Thomas RE. A cost and effects analysis of a kidney and cardiovascular disease treatment program in an Australian Aboriginal population. Adv Chronic Kid Dis 2005; 12: 22-31
10. Hoy WE, Mathews JD, Pugsley DJ et al. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int 1998; 54: 1296-1304
11. Hoy WE, White AV, Dowling A et al. Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. Kidney Int 2012; 81: 1026-1032
12. Hoy WE, White AV, Tipiloura B et al. The influence of birthweight, past poststreptococcal glomerulonephritis and current body mass index on levels of albuminuria in young adults: the multideterminant model of renal disease in a remote Australian Aboriginal population with high rates of renal disease and renal failure. Nephrol Dial Transplant. 2014; doi:10.1093/ndt/gfu241
13. Nenov VD, Taal MW, Sakharova OV et al. The multi-hit nature of chronic renal disease. Curr Opin Nephrol Hypertension 2000; 9: 85-97
14. Hoy WE, Wang Z, Baker PRA et al. The natural history of renal disease in Australian Aborigines. Part 2. Albuminuria predicts natural death and renal failure. Kidney Int 2001; 60: 249-256
15. Wang Z., Hoy WE, Wang Z. Comparison of the predictive value of urine ACR by immunoassay and by HPLC for natural death in an Australian Aboriginal population. Am J Kid Dis 2008; 52: 672-682
16. Peach HG, Pearce DC, Farish SJ. Age-standardised mortality and proportional mortality analyses of aboriginal and nonaboriginal deaths in metropolitan, rural and remote areas. Aust J Rural Health 1998; 6: 36-41
17. Duffy DL, Hoy WE, Hayhurst B et al. Familial aggregation of albuminuria, renal insufficiency and arterial hypertension in an Aboriginal Australian community. Nephrology
18. McDonald SP, Hoy WE, Maguire GP et al. The p53Pro72Arg polymorphism is associated with albuminuria among Aboriginal Australians. J Am Soc Nephrol 2002; 13: 677-683
19. Moore L, Lloyd MS, Pugsley DJ et al. Renal disease in an Australian Aboriginal population: a pathologic study. Nephrology 1996; 2: 315-321
20. Howard D, Davis J, Pugsley JD et al. Morphologic correlates of renal disease in a high risk Australian Aboriginal community. Aust NZ Soc Nephrol, 32nd Annual Meeting, 1996. Kidney Int 1997; 51: 1318
21. Bertram JF, Young RJ, Seymour AE et al. Glomerulomegaly in Australian Aborigines. Nephrology 1998; 4(Suppl): 46-53
22. Young RJ, Hoy WE, Kincaid Smith P et al. Glomerular size and glomerulosclerosis in Australian Aborigines. Am J Kidney Dis 2000; 36: 481-489
23. Hoy WE, Baker PRA, Kelly A et al. Sustained reduction at four years in natural deaths and renal failure from a systematic renal and cardiovascular treatment program in an Australian Aboriginal community. Kidney Int 2003; 63: S66-S73
24. Hoy WE, Kondalsamy Chennakesavan S, Katz I. A chronic disease outreach program for Australian Aboriginal communities. Kidney Int 2005; 68: S76-S82
25. Hoy WE, McDonald SP. Albuminuria, marker or target in indigenous populations in the role of albuminuria in health and disease: predicting outcomes and target for therapy. Kidney Int Suppl 2004; 92(Suppl): S25-S31
26. Hoy WE, Kondalsamy Chennakesavan S, Shaw J et al. Estimating the excess risk for hypertension, renal disease and diabetes among of Aboriginal in remote communities in the Northern Territory. Aust NZ J Public Health 2007; 31: 177-183
27. Hoy WE, Davey RL, Sharma S et al. Chronic disease profiles in remote Aboriginal settings, and implications for health services planning. Aust NZ J Pub Health 2010; 34: 11-18
28. Hoy WE. Setting up prevention and detection programs for kidney and related chronic disease. Ethnic Dis 2006; 16(Suppl 2): S72-S78
29. Al Salmi I, Hoy WE, Kondalsamy-Chennakesavan S et al.Disorders of glucose regulation in adults and birth weight: results from the Australian Diabetes, Obesity and Lifestyle (AUSDIAB) Study. Diabetes Care 2008; 31: 159-164
30. Al Salmi I, Hoy WE, Kondalsamy-Chennakes S et al. Birth weight and stages of CKD: a case-control study in an Australian population. Am J Kidney Dis 2008; 52: 1070-1078
31. Hoy WE, Samuel T, Mott SA et al. Renal biopsy rates and findings among Indigenous Australians: a nationwide review. Kidney Int 2012; 82: 1321-1331
32. Hoy WE, Hughson MD, Singh GR et al. Reduced nephron number and glomerulomegaly in Australian Aborigines: a group at high risk for renal disease and hypertension. Kidney Int 2006; 70: 104-110
33. Hughson MD, Farris AB III, Denton-Douglas R et al. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int 2003; 63: 2113-2122
34. Australian Bureau of Statistics. The health and welfare of Australia's Aboriginal and Torres Strait Islander Peoples. Cat no. 4704.0. Australian Bureau of Statistics, Canberra. http://wcitlibrary.pbworks.com/f/The+Health+and+Welfare+of+ Australias+Aboriginal+and+Torres+Strait+Islander+Peoples +2001.pdf (15 August 2013, date last accessed), 2001
35. Australian Institute of Health andWelfare. Rural, regional and remote health: A study on mortality. Rural Health Series, No 2. Cat no. PHE 45. AIHW, Canberra, 2003
36. Cass A, Cunningham J, Wang Z et al. Regional variation in the incidence of end stage renal disease in indigenous Australians. Med J Aust 2001; 175: 24-27
37. Australian Institute of Health and Welfare 2011. Chronic kidney disease in Aboriginal and Torres Strait Islander people. Cat no. PHE 151, AIHW, Canberra, 2011. http://www.aihw.gov. au/publication-detail/?id=10737419983 (15 August 2013, date last accessed)
38. Cass A, Cunningham J, Snelling P et al. End-stage renal disease in indigenous Australians: A disease of disadvantage. Ethnic Dis 2002; 12: 373-378
39. Grace BS, Clayton P, Cass A et al. Socio-economic status and incidence of renal replacement therapy: a registry study of Australian patients. Nephrol Dial Transplant 2012; 27: 4173-4180. Epub 23 Aug 2012
40. Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am. J. Kidney Dis 1994; 23: 171-175
41. McDonald S, Excell L, Jose M. End-stage kidney disease among indigenous peoples of Australia and New Zealand. In: McDonald S, Excell L, Livingston B (eds). ANZDATA Registry Report 2010. Adelaide, SA: Australia and New Zealand Dialysis and Transplant Registry, 2011, pp. 12.1-12.12
42. Preece C. Developing a model of care to improve the health and wellbeing for indigenous people to receiving renal dialysis treatment. Masters by Research Thesis, Queensland University of Technology, Brisbane, Queensland, 2010. http://eprints.qut.edu.au/37644/(15 August 2013, date last accessed)
43. Cass A, Brown A, Togni S et al. Central Australia Renal Study, June 2011. Part 3: Technical Report. Australian Department of Health and Ageing, 2011. (1 August 2013, date last accessed)
44. Anderson K, Devitt J, Cunningham J et al. "All they said was my kidneys were dead": Indigenous Australian patients' understanding of their chronic kidney disease. Med J Aust. 2008; 189: 499-503
45. Sleath E. Dialysis on country. ABC Alice Springs. Australian Broadcasting Corporation, 10 May 2012. http://www.abc.net. au/local/stories/2012/04/30/3492195.htm (15 August 2013, date last accessed)
46. Templeton A. Dialysis patients living in city's parks. Townsville Bulletin, 9 July 2012. http://www.townsvillebulletin.com.au/article/2012/07/09/345171-news.html (15 August 2013, date last accessed)
47. Medew J. Lives at risk in outback border squabble. The Age, 12 November 2009. http://www.theage.com.au/national/livesat-risk-in-outback-border-squabble-20091111-i9z3.html (9 April 2010, date last accessed)
48. Marley JV, Dent HK, Wearne M et al. Haemodialysis outcomes of Aboriginal and Torres Strait Islander patients of remote Kimberley region origin. Med J Aust 2010; 193: 516-520
49. Hoy WE, Kincaid-Smith P, Hughson MD et al. CKD in Aboriginal Australians. Am J Kidney Diseases 2010; 56: 983-993
50. Cass A, Chadban S, Gallgher M et al. The economic impact of end-stage kidney disease in Australia. Projections to 2020. Kidney Health Australia, 2010. http://www.kidney.org.au (15 August 2013, date last accessed)
51. Department of Health and Aging. Health assessment for Aboriginal and Torres Strait Islander People (MBS Item715). Commonwealth of Australia, Canberra, 2012, http://www.health. gov.au/internet/main/publishing.nsf/Content/mbsprimarycare-ATSI-mbsha-resource-kit. (15 August 2013, date last accessed)
52. Department of Health and Aging. Section 100-highly specialised drugs program. Commonwealth of Australia, Canberra. http://www.pbs.gov.au/info/browse/section-100/s100-highlyspecialised-drugs (15 August 2013, date last accessed)
53. The Pharmacy Guild of Australia. Quality use of Medicines Maximised for Aboriginal and Torres Strait Islander People (QUMAX). 5th Community Pharmacy Agreement. Department of Health and Aging, Commonwealth of Australia, 2013. http://www.5cpa.com.au/docs/librariesprovider5/publicdocuments/resources/standards-and-guidelines/qumaxprogram-specific-guidelines.pdf?sfvrsn=4 (15 August 2013, date last accessed)
54. Hoy WE, Swanson CE, Manning R et al. A comparison of PBS medications in two Remote Central Australian Aboriginal Communities. Mini Oral. In: ANZSN 49th Annual scientific Meeting, 9-11 September, Brisbane Convention and Exhibition Centre, Brisbane, 2013. Accepted for the ANZSN 49th Annual Scientific Meeting 2013-04-22
55. National Aboriginal Community Controlled Health Organisation (NACCHO). http://www.naccho.org.au/(15 August 2013, date last accessed)
56. Central Australian Rural Practitioners Association. CARPA Reference Manual. 4th edn. Australia: Central Australian Rural Practitioners Association (CARPA), 2012. http://www.carpa. org.au/manual-reference.htm (15 August 2013, date last accessed)
57. Brooker C. Polypill trial to start in Australia soon. Cardiovascular. Medical Observer. 4 June 2010. http://www.medical observer.com.au/news/polypill-trial-to-start-in-australia-soon (15 August 2013, date last accessed)
58. Andreasyan K, Hoy WE. Recent patterns in chronic disease mortality in remote living Aboriginal Australians. BMC Public Health 2010; 10: 483
59. Wang Z, Hoy WE. Decreasing rates of natural death in a remote Australian Aboriginal community. ANZJPH 2013; 37: 365-370
60. Wang Z, Scott J, Hoy WE. Trends in health status and chronic disease risk factors over 10-14 years in a remote Australian community: amatched pair study. ANZJPH 2013; 38: 73-77